| 449 |
12: AchE Inhibition |
444: Increased, Atrioventricular block and bradycardia |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 450 |
12: AchE Inhibition |
445: Respiratory distress/arrest |
Nov 29, 2016 |
Dec 20, 2019 |
1 AOP
|
| 451 |
12: AchE Inhibition |
39: Increased Cholinergic Signaling |
Nov 29, 2016 |
Dec 20, 2019 |
2 AOPs
|
| 452 |
12: AchE Inhibition |
351: Increased Mortality |
Nov 29, 2016 |
Dec 20, 2019 |
1 AOP
|
| 453 |
12: AchE Inhibition |
442: Decreased, Population trajectory |
Nov 29, 2016 |
Dec 20, 2019 |
None
|
| 454 |
10: ACh Synaptic Accumulation |
444: Increased, Atrioventricular block and bradycardia |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 456 |
10: ACh Synaptic Accumulation |
39: Increased Cholinergic Signaling |
Nov 29, 2016 |
Dec 20, 2019 |
3 AOPs
|
| 457 |
39: Increased Cholinergic Signaling |
445: Respiratory distress/arrest |
Nov 29, 2016 |
Dec 20, 2019 |
1 AOP
|
| 459 |
10: ACh Synaptic Accumulation |
12: AchE Inhibition |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 460 |
446: Reduction of testosterone |
414: Increase, Luteinizing hormone (LH) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 461 |
414: Increase, Luteinizing hormone (LH) |
416: Increase proliferation, Leydig cell |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 462 |
415: Hyperplasia, Leydig cell |
406: decreased, Fertility |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 472 |
327: Accumulation, Fatty acid |
291: Accumulation, Triglyceride |
Nov 29, 2016 |
May 28, 2024 |
1 AOP
|
| 473 |
18: Activation, AhR |
451: Inhibition, Mitochondrial fatty acid beta-oxidation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 475 |
451: Inhibition, Mitochondrial fatty acid beta-oxidation |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 476 |
456: Suppression, Constitutive androstane receptor, NR1I3 |
167: Activation, LXR |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 477 |
456: Suppression, Constitutive androstane receptor, NR1I3 |
228: demethylation, PPARg promoter |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 479 |
167: Activation, LXR |
457: Activation, SREBF1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 482 |
457: Activation, SREBF1 |
458: Increased, De Novo FA synthesis |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 483 |
66: Activation, ChREBP |
458: Increased, De Novo FA synthesis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 484 |
458: Increased, De Novo FA synthesis |
454: Increased, Triglyceride formation |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 486 |
454: Increased, Triglyceride formation |
459: Increase, Liver steatosis |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 487 |
228: demethylation, PPARg promoter |
457: Activation, SREBF1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 489 |
457: Activation, SREBF1 |
462: Up Regulation, SCD-1 |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 490 |
167: Activation, LXR |
463: Up Regulation, FAS |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|